BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World J Gastroenterol 2016; 22(6): 2133-2141 [PMID: 26877618 DOI: 10.3748/wjg.v22.i6.2133]
URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2133.htm
Number Citing Articles
1
Thomas Jouve, Johan Noble, Lionel Rostaing, Paolo Malvezzi. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimizationExpert Opinion on Drug Safety 2019; 18(4): 285 doi: 10.1080/14740338.2019.1599858
2
Pan Kun-ming, Chen Can, Xu Qing, Wu Wei, Lv Qian-zhou, Li Xiao-yu. Calcineurin inhibitor–associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in ChinaEuropean Journal of Clinical Pharmacology 2021; 77(7): 961 doi: 10.1007/s00228-021-03095-z
3
Xiao-fu Xiong, Ding-ding Chen, Huai-jun Zhu, Wei-hong Ge. Prognostic Value of Endogenous and Exogenous Metabolites in Liver TransplantationBiomarkers in Medicine 2020; 14(12): 1165 doi: 10.2217/bmm-2020-0073
4
Zhen Zhang, Jianyun Sun, Meng Guo, Xuemin Yuan. Progress of new-onset diabetes after liver and kidney transplantationFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1091843
5
Tianwei Lan, Xin Zhang, Qian Yu. Anaemia associated with Tacrolimus: A case report and literature reviewJournal of Clinical Pharmacy and Therapeutics 2020; 45(6): 1497 doi: 10.1111/jcpt.13238
6
Shingo Shimada, Katsunori Miyake, Deepak Venkat, Humberto Gonzalez, Dilip Moonka, Atsushi Yoshida, Marwan Abouljoud, Shunji Nagai. Clinical characteristics of new‐onset diabetes after liver transplantation and outcomesAnnals of Gastroenterological Surgery 2024; 8(3): 383 doi: 10.1002/ags3.12775
7
Mark W. Russo, William Wheless, Dionisios Vrochides. Management of long-term complications from immunosuppressionLiver Transplantation 2024; 30(6): 647 doi: 10.1097/LVT.0000000000000341
8
Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima, Shinji Uemoto. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic functionSurgery Today 2017; 47(6): 733 doi: 10.1007/s00595-016-1444-z
9
Johan Noble, Florian Terrec, Paolo Malvezzi, Lionel Rostaing. Adverse effects of immunosuppression after liver transplantationBest Practice & Research Clinical Gastroenterology 2021; : 101762 doi: 10.1016/j.bpg.2021.101762
10
Eloi Chevallier, Thomas Jouve, Lionel Rostaing, Paolo Malvezzi, Johan Noble. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppressionExpert Review of Clinical Pharmacology 2021; 14(1): 55 doi: 10.1080/17512433.2021.1851596
11
Abbie D. Leino, Manjunath P. Pai. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose SelectionClinical Pharmacokinetics 2020; 59(11): 1317 doi: 10.1007/s40262-020-00923-w
12
Chih-Yang Hsiao, Ming-Chih Ho, Cheng-Maw Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver TransplantationJournal of Personalized Medicine 2021; 11(2): 90 doi: 10.3390/jpm11020090
13
Prani Paka, Sarah R Lieber, Ruth-Ann Lee, Chirag S Desai, Robert E Dupuis, Alfred Sidney Barritt. Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic reviewWorld Journal of Transplantation 2018; 8(3): 75-83 doi: 10.5500/wjt.v8.i3.75
14
Antônio Ricardo Cardia Ferraz de Andrade, Helma P. Cotrim, Paulo L. Bittencourt, Carolina G. Almeida, Ney Christian Amaral Boa Sorte. Nonalcoholic steatohepatitis in posttransplantation liver: Review articleRevista da Associação Médica Brasileira 2018; 64(2): 187 doi: 10.1590/1806-9282.64.02.187
15
Aloysious D. Aravinthan, Waleed Fateen, Adam C. Doyle, Suresh V. Venkatachalapathy, Assaf Issachar, Zita Galvin, Gonzalo Sapisochin, Mark S. Cattral, Anand Ghanekar, Ian D. McGilvray, Markus Selzner, David R. Grant, Nazia Selzner, Leslie B. Lilly, Eberhard L. Renner, Mamatha Bhat. The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver TransplantationTransplantation 2019; 103(12): 2523 doi: 10.1097/TP.0000000000002757
16
Sonja Beckmann, Gerda Drent, Todd Ruppar, Nataša Nikolić, Sabina De Geest. Body Weight Parameters are Related to Morbidity and Mortality After Liver Transplantation: A Systematic Review and Meta-analysisTransplantation 2019; 103(11): 2287 doi: 10.1097/TP.0000000000002811
17
Jongman Kim, Jae-Won Joh, Kwang-Woong Lee, Dong Lak Choi, Hee-Jung Wang. Safety and efficacy of early corticosteroid withdrawal in liver transplant recipients: A randomized controlled trialAnnals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2): 238 doi: 10.14701/ahbps.23-129
18
Mariana Baldini Campos, Cínthia Minatel Riguetto, Ilka de Fátima Santana Ferreira Boin, Arnaldo Moura. Risk factors associated with diabetes after liver transplantArchives of Endocrinology and Metabolism 2022;  doi: 10.20945/2359-3997000000447
19
Rohit Mehtani, Sanjiv Saigal. Long Term Complications of Immunosuppression Post Liver TransplantJournal of Clinical and Experimental Hepatology 2023; 13(6): 1103 doi: 10.1016/j.jceh.2023.06.007
20
Tommaso Maria Manzia, Roberta Angelico, Luca Toti, Cristina Angelico, Claudia Quaranta, Alessandro Parente, Francesca Blasi, Samuele Iesari, Daniele Sforza, Leonardo Baiocchi, Jan Lerut, Giuseppe Tisone. Longterm Survival and Cost‐Effectiveness of Immunosuppression Withdrawal After Liver TransplantationLiver Transplantation 2018; 24(9): 1199 doi: 10.1002/lt.25293
21
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver TransplantationTransplantation 2019; 103(3): 470 doi: 10.1097/TP.0000000000002532
22
Ruiping Bai, Rui An, Siyu Chen, Wenkang Ding, Mengwen Xue, Ge Zhao, Qingyong Ma, Xin Shen. Risk factors and prediction score for new‐onset diabetes mellitus after liver transplantationJournal of Diabetes Investigation 2024;  doi: 10.1111/jdi.14204
23
Ali R Chaitou, Surbhi Valmiki, Mrinaal Valmiki, Maria Zahid, Mohamed A Aid, Peter Fawzy, Safeera Khan. New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive TherapyCureus 2022;  doi: 10.7759/cureus.23635
24
Venkat Bhat, Mahmood Tazari, Kymberly D. Watt, Mamatha Bhat. New-Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long-Term Survival After Liver Transplant: A Machine Learning ApproachMayo Clinic Proceedings 2018; 93(12): 1794 doi: 10.1016/j.mayocp.2018.06.020
25
Chang Seong Kim, Ansuja Pulickal Mathew, Arathy Vasukutty, Saji Uthaman, Soo Yeon Joo, Eun Hui Bae, Seong Kwon Ma, In-Kyu Park, Soo Wan Kim. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritisJournal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00857-w
26
Yip Han Chin, Hon Qin Marcus Tan, Cheng Han Ng, Darren Jun Hao Tan, Snow Yunni Lin, Daniel Q. Huang, Chin Meng Khoo, Mark Dhinesh Muthiah. A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver TransplantationJournal of Clinical Medicine 2021; 10(5): 1045 doi: 10.3390/jcm10051045